Cargando…
Gonadotropin-releasing Hormone Agonist Overuse: Urologists’ Response to Reimbursement and Characteristics Associated with Persistent Overuse
BACKGROUND: Medicare reimbursement cuts have been associated with declining Gonadotropin-releasing Hormone (GnRH) agonist overuse in localized prostate cancer. Medical school affiliation and foreign training have been associated with persistent overuse. However, physician-level prescribing changes a...
Autores principales: | Ellis, Shellie D., Nielsen, Matthew E., Carpenter, William R., Jackson, George L., Wheeler, Stephanie B., Liu, Huan, Weinberger, Morris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430363/ https://www.ncbi.nlm.nih.gov/pubmed/25849354 http://dx.doi.org/10.1038/pcan.2015.10 |
Ejemplares similares
-
Ultrasound Use and “Overuse”
por: Mariani, Peter J.
Publicado: (2010) -
Management of medication overuse (MO) and medication overuse headache (MOH) S1 guideline
por: Diener, Hans-Christoph, et al.
Publicado: (2022) -
Gonadotropin releasing hormone agonists: Expanding vistas
por: Magon, Navneet
Publicado: (2011) -
Antibiotic Overuse and Stewardship at Hospital Discharge: The Reducing Overuse of Antibiotics at Discharge Home Framework
por: Vaughn, Valerie M, et al.
Publicado: (2021) -
Overuse, Overdose, Overdiagnosis… Overreaction?
por: Ho, ELM
Publicado: (2010)